TYPE1DIABETES
Clinical trials for TYPE1DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE1DIABETES trials appear
Sign up with your email to follow new studies for TYPE1DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common diabetes pill stop dangerous side effects in type 1 patients?
Disease control Not yet recruitingThis study looks at whether adding pioglitazone (a type 2 diabetes drug) can block harmful side effects caused by dapagliflozin in people with type 1 diabetes. Dapagliflozin can increase liver glucose, fat breakdown, and ketone production, which may lead to a dangerous condition …
Matched conditions: TYPE1DIABETES
Phase: PHASE3 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Sleep program aims to improve diabetes control
Symptom relief Not yet recruitingThis study tests a cognitive behavioral program to improve sleep and glucose levels in adults with type 1 diabetes. About 48 people aged 31 to 75 will join. The program focuses on sleep habits and uses activity monitors and glucose trackers to measure changes.
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
Diet drinks under the microscope: new study targets heart risks in young diabetics
Knowledge-focused Not yet recruitingThis study looks at how non-nutritive sweeteners (like those in diet drinks) affect the heart and blood vessels of young adults with type 1 diabetes. Twenty people aged 15-24 will drink a sports drink and have their blood vessel function measured. The goal is to understand if the…
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC